Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy

Developmental Medicine and Child Neurology

Volumn 42, Issue 9, 2000, Pages 634-645

  Butler, Charlene ^b   Campbell, Suzann ^b   Adams, Richard ^a   Abel, Mark ^a   Chambers, Henry ^a   Goldstein, Murray ^a   Leach, Judy ^a   Darrah, Johanna ^a   Msall, Michael ^a   Edgar, Terrance ^a   McLaughlin, John ^a   Damiano, Diane ^a   Susan Stott, N ^a   Samson Fang, Lisa ^a   Logan, Lynne ^a   Albright, Leland ^a   Armstrong, Robert ^a   O'Donnell, Maureen ^a  

^a American Academy for Cerebral Palsy and Developmental Medicine   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; BACLOFEN;

CENTRAL NERVOUS SYSTEM DISEASE; CEREBRAL PALSY; CHILDHOOD DISEASE; CLINICAL TRIAL; COST UTILITY ANALYSIS; DAILY LIFE ACTIVITY; DISABILITY; DOSE RESPONSE; DRUG COST; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DYSTONIA; EVIDENCE BASED MEDICINE; FUNCTIONAL ASSESSMENT; GASTROINTESTINAL SYMPTOM; HUMAN; MUSCLE HYPOTONIA; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; SEIZURE; SOMNOLENCE; SPASTICITY; TREATMENT OUTCOME;

BACLOFEN; CEREBRAL PALSY; CHILD; CLINICAL TRIALS; HUMANS; INJECTIONS, SPINAL; LEG; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; TREATMENT OUTCOME;

EID: 0033830212     PISSN: 00121622     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0012162200001183     Document Type: Review

References (33)

1. Assessing 'best evidence': Issues in grading the quality of studies for systematic reviews
2. Evaluating research in developmental disabilities: A conceptual framework for reviewing treatment outcomes
3. Rules of evidence and clinical recommendations on the use of antithrombotic agents
4. Spasticity: The fable of a neurological demon and the emperor's new therapy
5. The relationship of voluntary movement to spasticity in the upper motor neuron syndrome
6. Management of intractable spasticity with intrathecal baclofen
7. Intrathecal baclofen in cerebral palsy movement disorders
8. Intrathecal baclofen alleviates spinal cord spasticity
9. Long-term intrathecal baclofen for treatment of spasticity
10. Intrathecal baclofen for severe spasticity
11. Intrathecal baclofen for spasticity in cerebral palsy
12. Continuous intrathecal baclofen infusion for spasticity of cerebral origin
13. Effects of continuous intrathecal baclofen infusion and selective posterior rhizotomy on upper extremity spasticity
14. Intrathecal baclofen for motor disorders
15. Cost analysis of continuous intrathecal baclofen versus selective functional posterior rhizotomy in the treatment of spastic quadriplegia associated with cerebral palsy
16. Seizures in epileptic cerebral palsy patients receiving intrathecal baclofen infusion
17. Changes in voluntary motor control induced by intrathecal baclofen in patients with spasticity of different etiology
18. Multidimensional assessment of motor function in a child with cerebral palsy following intrathecal administration of baclofen
19. Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin
20. Functional changes noted following treatment of individuals with cerebral palsy with intrathecal baclofen
21. Effect on ambulation of continuous intrathecal baclofen infusion
22. Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy
23. Intrathecal baclofen for management of spastic cerebral palsy: Multicenter trial
24. Intrathecal baclofen for intractable cerebral spasticity: A prospective placebo-controlled, double-blind study
25. Implanted pump systems for treatment of spasticity
26. Long-term intrathecal baclofen treatment in supraspinal spasticity
27. Chronic intrathecal baclofen administration in severe spasticity
28. Infusion of intrathecal baclofen for generalized dystonia in cerebral palsy
29. Intrathecal baclofen for intractable axial dystonia
30. Increased dystonia after intrathecal baclofen
31. Continuous intrathecal baclofen infusion for symptomatic generalized dystonia
32. Reliability and responsiveness of the Barry-Albright Dystonia Scale